Sleep, sleep-disordered breathing and metabolic consequences Source: Eur Respir J 2009; 34: 243-260 Year: 2009
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007
Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Source: Eur Respir J 2008; 32: 1082-1095 Year: 2008
Diabetes and metabolic aspects of OSA Source: Eur Respir Mon 2010; 50: 189-215 Year: 2010
Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 17: 838-847 Year: 2001
Metabolic aspects of obstructive sleep apnoea syndrome Source: Eur Respir Rev 2009; 18: 113-124 Year: 2009
Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003
Clinical, polysomnographic, antrophometric and inflammatory profile of patients with obstructive sleep apnea syndrome based on gender Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
The economic consequences of snoring, obstructive sleep apnea and obesity hypoventilation syndrome Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007